World Wildlife Fund Launches New PSA to Combat Plastic Pollution featuring U2 song ‘Beautiful Day’
19 avr. 2024 09h15 HE
|
World Wildlife Fund
Washington, DC, April 19, 2024 (GLOBE NEWSWIRE) -- Today, World Wildlife Fund (WWF), the global conservation nonprofit, released a new Public Service Announcement (PSA) ahead of Earth Day (April...
Novartis’ Intravenous Formulation of Cosentyx Impacting Prescriber Preferences in Psoriatic Arthritis Treatment, While Pending Launch of UCB’s Bimzelx Poised to Further Disrupt the Market
16 avr. 2024 14h06 HE
|
Spherix Global Insights
EXTON, PA, April 16, 2024 (GLOBE NEWSWIRE) -- In October of 2023, the US FDA approved Novartis’ intravenous (IV) formulation of Cosentyx (secukinumab) for the treatment of psoriatic arthritis (PsA),...
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilization of IL-17 Inhibitors
22 janv. 2024 10h47 HE
|
Spherix Global Insights
EXTON, PA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Since the first US FDA-approved tumor necrosis factor (TNF) inhibitor in 2002 for the treatment of psoriatic arthritis (PsA), TNF’s have upheld their...
En tant qu'allié dévoué, le Ruban blanc publie des Vies en Bref qui traitent de la violence à l'encontre des communautés transgenres
13 nov. 2023 06h30 HE
|
Ruban blanc
TORONTO, 13 nov. 2023 (GLOBE NEWSWIRE) -- Le Ruban blanc lance sa toute dernière campagne, Vies en Bref, qui suit la vie d'une femme transgenre depuis sa transition. Cette campagne se penche sur son...
As a committed ally, White Ribbon releases Short Life Stories addressing violence against the transgender communities
13 nov. 2023 06h30 HE
|
White Ribbon
As a committed ally, White Ribbon releases Short Life Stories addressing violence against the transgender communities.
Consecutive Use of TNF-Inhibitors for the Treatment of Psoriatic Arthritis at Lowest Point Recorded, as Use of Biologics with Alternate Mechanisms of Actions Continue to Grow, According to Spherix Global Insights
03 oct. 2023 13h57 HE
|
Spherix Global Insights
Exton, Pennsylvania, Oct. 03, 2023 (GLOBE NEWSWIRE) -- US rheumatologists (n=204) report nearly two-thirds of their psoriatic arthritis (PsA) patients are undergoing treatment with advanced systemic...
Medical Courier Market to Hit $10.96 Billion Propelled by Medical Supplies and Equipment Segment During 2020-2030 | The Insight Partners
03 oct. 2023 09h36 HE
|
The Insight Partners
Pune, India, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Medical courier is the supply of samples and equipment related to healthcare and medical requirements can sometimes be urgent and critical. A medical...
Wake Up Narcolepsy Debuts Public Service Announcement in Collaboration with Red Square Pictures
11 juil. 2023 11h17 HE
|
Wake Up Narcolepsy
WORCESTER, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Wake Up Narcolepsy (WUN), a national leader for research and awareness, premiered its Narcolepsy public service announcement in partnership with Red...
Curium Receives Positive CHMP Opinion of PYLCLARI® for Primary Staging of Patients With High-Risk PCa Prior to Initial Curative Therapy and to Localize Recurrence of PCa in Patients With a Suspected Recurrence Based on Increasing Serum Prostate-Specific Antigen (PSA) Levels After Primary Treatment With Curative Intent
26 mai 2023 03h42 HE
|
Curium
If approved for Europe, PYLCLARI® (INN: Piflufolastat (18F) formerly known as [18F]-DCFPyL) will offer prostate cancer patients access to a diagnostic imaging agent more sensitive than conventional...
Prostate Cancer Diagnostics Market to Exceed US$ 8 Billion by 2031 as Adoption of Generic Drugs Gains Momentum Worldwide | Fact.MR Report
05 avr. 2023 10h00 HE
|
FACT.MR
Rockville , April 05, 2023 (GLOBE NEWSWIRE) -- The global prostate cancer diagnostics market is projected to reach US$ 8 billion in 2031. It is anticipated to register growth at a CAGR of 10% from...